Vor Biopharma Inc. Common Stock
VORVor Biopharma Inc. (VOR) is a biotechnology company focused on developing targeted therapies for cancer using cell engineering technologies. The company aims to create treatments that selectively eliminate cancer cells while preserving healthy cells, leveraging its proprietary gene-editing platforms. Founded to address challenges in oncology, Vor Biopharma emphasizes precision medicine approaches to improve patient outcomes.
Company News
Vor Biopharma is conducting a public offering of 10 million shares at $10 per share, expecting to raise $100 million. The offering includes an option for underwriters to purchase an additional 1.5 million shares.
Vor Biopharma (VOR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
A more selective small-cap index has consistently outperformed the Russell 2000
